Navigation Links
Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
Date:5/21/2009

EXPanding AlzhEimer's Disease InvestigaTIONs

The EXPEDITION clinical trials are identical multicenter, randomized, double-blind, placebo-controlled trials. Patients enrolled in the trials will be randomized in a 1:1 ratio (500 patients in each trial arm) to receive intravenous infusions of either placebo or 400 mg of solanezumab once every four weeks. Patients who are taking currently available symptomatic treatments for Alzheimer's disease can continue treatment during their participation in the EXPEDITION trials. The primary objective of both trials is to test whether solanezumab will slow the cognitive and functional decline of Alzheimer's disease patients as compared with placebo. These outcomes will be analyzed using measures of the Alzheimer's Disease Assessment Scale-Cognitive subscore (ADAS-COG(11)), which measures cognitive function with an emphasis on memory, and the Alzheimer's Disease Cooperative Study - Activities of Daily Living scale (ADCS-ADL), which measures the ability to independently perform daily activities such as eating, bathing, and using the telephone. Secondary objectives of the trials include different clinical benefits as measured by several brain-scanning and biochemical biomarkers and ratings scales, and quality of life impact.

"Current therapies available to treat Alzheimer's disease may help with symptoms, but they haven't been proven to change the disease progression," said Eric Siemers M.D., Medical Director, Alzheimer's disease research for Eli Lilly and Company. "Biomarker results from a Phase II solanezumab trial give us hope that Lilly is on a path toward a treatment that may slow the rate of progression of Alzheimer's disease."

EXPEDITION will be conducted in Argentina, Brazil, Canada, Japan, and United States. EXPEDITION 2 will be conducted in Australia, France, Germany, Italy, Japan, Korea, Poland, Russia, Spain, Sweden, Taiwan, United Kingdom, and Un
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
2. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
3. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
4. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
5. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
6. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
7. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
8. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
9. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
10. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
11. Lilly and TransPharma Medical Announce Licensing and Development Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... Medical is very pleased to announce the appointment of Mr. ... Officer.  Mark was promoted from his current role of Chief ... facilities in Massachusetts , Mississippi ... in 2012 with 20+ years of broad-based operations, sales, engineering ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Reportlinker.com announces that a new ... its catalogue: Retinal ... Assessment and Market Forecasts to 2017 ... Retinal Vein Occlusion (RVO) ...
... Pharmaceutical Group (NYSE: SCR ) ("Simcere" or ... development, manufacturing, and marketing of branded and proprietary pharmaceuticals ... of shareholders (the "Meeting") will be held on Thursday, ... meeting will be held in No.699-18, Xuanwu Avenue, Xuanwu ...
Cached Medicine Technology:Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 10Simcere Pharmaceutical Group Provides Notice of Annual General Meeting 2
(Date:7/9/2014)... common type of lung cancer, researchers have uncovered mutations ... forming tumors. The new knowledge may expand treatments for ... already are available or are in clinical trials. , ... The Cancer Genome Atlas (TCGA), including researchers at Washington ... School and other institutions, studied tumors from 230 patients ...
(Date:7/9/2014)... Center paint a relatively optimistic picture of women,s chances ... spread to the chest wall or skin, but not ... regardless of size and whether they have involved lymph ... called "locally advanced" tumors, suggesting that they are a ... Locally advanced breast cancers of this and other types ...
(Date:7/9/2014)... users in Russia might contribute to HIV transmission ... by researchers from Boston University Schools of Medicine ... Pavlov State University, sought to discover the effect ... a cohort of HIV-positive people with lifetime of ... by police were more likely to share needlesincreasing ...
(Date:7/9/2014)... and subjective, the human brain turns them into ... different senses, situations and even people, reports a ... , "We discovered that fine-grained patterns of neural ... the brain associated with emotional processing, act as ... feeling," says Anderson, associate professor of human development ...
(Date:7/9/2014)... been a sharp increase in the number of cancer ... online, interactive service that allows patients to view laboratory ... appointments, and renew prescriptions. , Over a six-year period, ... each year increased five-fold, while the number of total ... a study by Dr. David Gerber , Associate ...
Breaking Medicine News(10 mins):Health News:Lung cancer study hints at new treatments 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Study cracks how the brain processes emotions 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3
... the Public Health Grid (PHGrid) technology during the 2009 ... and disease-control agencies when the next emergent disease appears, ... Journal of Grid and Utility Computing . Terry ... Control and Prevention, in Atlanta, Georgia, working with informatics ...
... is an EU-funded research project that develops objective ... Alzheimer,s disease. Diagnosis requires a holistic view of ... as, clinical tests, imaging and blood samples. ... to develop an objective indicator to diagnose Alzheimer,s ...
... June 14 (HealthDay News) -- A mist inhaler with the ... of death among people with chronic obstructive pulmonary disease (COPD), ... soluble form of Spiriva (tiotropium) is approved in 55 countries, ... the powdered form of Spiriva is commonly used to treat ...
... (HealthDay News) -- Patients with early-stage chronic kidney disease are ... a certain hormone, a new study says. Endocrine hormone ... known that levels of FGF-23 increase as kidney function declines ... increased risk of death in patients with kidney failure. But ...
... , Preschool children seem to grasp the true concept of ... value of groups of objects greater than three, research at ... that there are three objects doesn,t have to involve counting. ... necessary to determine how many objects there are," said Elizabeth ...
... PHILADELPHIA Scientists at Harvard University have created a ... observation of early stages of ovarian cancer metastasis. ... that are necessary for the force-dependent processes associated with ... cell biology at Harvard University. These findings are ...
Cached Medicine News:Health News:A grid approach to pandemic disease control 2Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 2Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 3Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 4Health News:COPD Drug Via Mist Inhaler Could Raise Death Risk: Study 2Health News:Hormone Linked to Death Risk in Those With Early Kidney Disease 2Health News:Learning to count not as easy as 1, 2, 3 2
Custom Conjugation Services...
Iso-Electric Determination Kit; contains 1 bottle of 40 nm Naked Gold Iso-Electric Determination Kit to optimize gold conjugation of antibodies...
Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 12 OD...
Medicine Products: